1,048 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
JNJ Johnson & Johnson $139.96 $375.48B Uptrend
Article Searches
Dean Foods (DF) to Gain from Scozzafava's Elevation to COO http://www.zacks.com/stock/news/190428/dean-foods-df-to-gain-from-scozzafavas-elevation-to-coo?cid=CS-ZC-FT-190428 Sep 17, 2015 - Dean Foods (DF) announced Ralph Scozzafava as its new Chief Operating Officer
GW Pharmaceuticals Up on Encouraging Schizophrenia Data http://www.zacks.com/stock/news/190320/gw-pharmaceuticals-up-on-encouraging-schizophrenia-data?cid=CS-ZC-FT-190320 Sep 16, 2015 - GW Pharmaceuticals plc (GWPH) announced encouraging top-line data from an exploratory phase IIa study on cannabidiol in patients suffering from schizophrenia who had previously failed to respond adequately to first-line anti-psychotic medications.
AbbVie Seeks FDA Approval for Imbruvica's Label Expansion http://www.zacks.com/stock/news/190147/abbvie-seeks-fda-approval-for-imbruvicas-label-expansion?cid=CS-ZC-FT-190147 Sep 15, 2015 - AbbVie (ABBV) is looking to get Imbruvica approved in the U.S. for the front-line treatment of patients suffering from chronic lymphocytic leukemia.
3 Quality ETFs to Trump Market Turmoil http://www.zacks.com/stock/news/190016/3-quality-etfs-to-trump-market-turmoil?cid=CS-ZC-FT-190016 Sep 15, 2015 - Given heightened volatility and uncertainty, investors should invest in high-quality stocks through a basket form.
Why is Gilead (GILD) Raising a Whopping $10 Billion? http://www.zacks.com/stock/news/189833/why-is-gilead-gild-raising-a-whopping-%2410-billion?cid=CS-ZC-FT-189833 Sep 11, 2015 - Gilead Sciences, Inc. (GILD) announced successful pricing of its senior note offering worth $10 billion in aggregate principal amount.
Johnson & Johnson's (JNJ) CEO Alex Gorsky Presents at 2015 Wells Fargo 10th Annual Healthcare Conference (Transcript) http://seekingalpha.com/article/3503396-johnson-and-johnsons-jnj-ceo-alex-gorsky-presents-at-2015-wells-fargo-10th-annual-healthcare-conference-transcript?source=feed_sector_healthcare Sep 10, 2015 - Johnson & Johnson (NYSE:JNJ) 2015 Wells Fargo 10th Annual Healthcare Conference Call September 10, 2015, 12:25 PM ET Executives Alex Gorsky - Chairman of the Board of Directors and Chief Executive
Tetraphase's (TTPH) Antibiotic Fails in Phase III Study http://www.zacks.com/stock/news/189508/tetraphases-ttph-antibiotic-fails-in-phase-iii-study?cid=CS-ZC-FT-189508 Sep 09, 2015 - Tetraphase Pharmaceuticals (TTPH) announced that the IGNITE2 study on eravacycline for complicated urinary tract infections did not meet its primary endpoint.
Gilead Reports Encouraging Data on TAF-based HIV Regimen http://www.zacks.com/stock/news/188934/gilead-reports-encouraging-data-on-taf-based-hiv-regimen?cid=CS-ZC-FT-188934 Sep 03, 2015 - Gilead Sciences Inc. (GILD) announced positive data from a phase III study on fixed-dose combinations of Emtriva and tenofoviralafenamide for the treatment of HIV-1 infection.
Lannett (LCI) to Buy UCB's Specialty Generics Subsidiary http://www.zacks.com/stock/news/188921/lannett-lci-to-buy-ucbs-specialty-generics-subsidiary?cid=CS-ZC-FT-188921 Sep 03, 2015 - Lannett Company (LCI) inked a deal with UCB to buy its U.S. specialty generics subsidiary, Kremers Urban Pharmaceuticals Inc.
Stock Market News for September 01, 2015 http://www.zacks.com/stock/news/188481/stock-market-news-for-september-01-2015?cid=CS-ZC-FT-188481 Sep 01, 2015 - Benchmarks ended in the red on Monday after Federal Vice Chairman Stanley Fischer’s comments on Saturday left possibilities of September rate hike wide open

Pages: 1...99100101102103104105

<<<Page 104